Manufacturer of Controlled Substances; Notice of Registration; Cambridge Isotope Lab, 6633-6634 [2014-02207]

Download as PDF 6633 Federal Register / Vol. 79, No. 23 / Tuesday, February 4, 2014 / Notices is granted registration as an importer of the basic classes of controlled substances listed. Dated: January 15, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–02209 Filed 2–3–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Sigma Aldrich Research Biochemicals, Inc. Pursuant to 21 CFR 1301.33(a), this is notice that on November 19, 2013, Sigma Aldrich Research Biochemicals, Inc., 1–3 Strathmore Road, Natick, Massachusetts 01760–2447, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following classes of controlled substances: mstockstill on DSK4VPTVN1PROD with NOTICES Drug Schedule Cathinone (1235) .......................... Etorphine HCl (9059) ................... Methcathinone (1237) .................. Mephedrone(4-Methyl-Nmethylcathinone) (1248). Aminorex (1585) ........................... Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (MDMA) (7405). Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... 5-Methoxy-N,Ndiisopropyltryptamine (7439). 1-[1-(2-Thienyl)cyclohexyl] piperidine (TCP) (7470). N-Benzylpiperazine (BZP) (7493) MDPV(3,4Methylenedioxypyrovalerone) (7535). VerDate Mar<15>2010 20:14 Feb 03, 2014 I II I I I I I I I I I Drug Schedule Methylone(3,4-Methylenedioxy-Nmethylcathinone) (7540). Heroin (9200) ............................... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Nabilone (7379) ............................ 1-Phenylcyclohexylamine (7460) Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Ecgonine (9180) ........................... Levomethorphan (9210) ............... Levorphanol (9220) ...................... Meperidine (9230) ........................ Metazocine (9240) ........................ Methadone (9250) ........................ Morphine (9300) ........................... Thebaine (9333) ........................... Levo-alphacetylmethadol (9648) .. Remifentanil (9739) ...................... Sufentanil (9740) .......................... Carfentanil (9743) ......................... Fentanyl (9801) ............................ I I I II II II II II II II II II II II II II II II II II II II II The company plans to manufacture reference standards. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 7, 2014. Dated: January 15, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–02202 Filed 2–3–14; 8:45 am] BILLING CODE 4410–09–P I I DEPARTMENT OF JUSTICE I Drug Enforcement Administration I I I I I I I I Jkt 232001 Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey Pharmaceutical Materials, Inc. Pursuant to 21 CFR 1301.33(a), this is notice that on December 23, 2013, Johnson Matthey Pharmaceutical Materials, Inc., Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts 01434, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 Drug Amphetamine (1100) .................... Methylphenidate (1724) ................ Nabilone (7379) ............................ Hydrocodone (9193) ..................... Alfentanil (9737) ........................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Schedule II II II II II II II The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company’s customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 7, 2014. Dated: January 15, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–02208 Filed 2–3–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Cambridge Isotope Lab By Notice dated August 15, 2013, and published in the Federal Register on August 26, 2013, 78 FR 52802, Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company plans to utilize small quantities of the listed controlled substance in the preparation of analytical standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of E:\FR\FM\04FEN1.SGM 04FEN1 6634 Federal Register / Vol. 79, No. 23 / Tuesday, February 4, 2014 / Notices Cambridge Isotope Lab to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Cambridge Isotope Lab to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: January 15, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. factors in 21 U.S.C. 823(a), and determined that the registration of Euticals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Euticals, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. [FR Doc. 2014–02207 Filed 2–3–14; 8:45 am] Dated: Signed January 15, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. BILLING CODE 4410–09–P [FR Doc. 2014–02200 Filed 2–3–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Manufacturer of Controlled Substances, Notice of Registration, Euticals, Inc. By Notice dated August 22, 2013, and published in the Federal Register on August 29, 2013, 78 FR 53480, Euticals, Inc., 2460 W. Bennett Street, Springfield, Missouri 65807–1229, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule mstockstill on DSK4VPTVN1PROD with NOTICES Gamma Hydroxybutyric Acid (2010). Amphetamine (1100) .................... Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Phenylacetone (8501) ................... Methadone Intermediate (9254) ... Tapentadol (9780) ........................ 20:14 Feb 03, 2014 By Notice dated August 29, 2013, and published in the Federal Register on September 6, 2013, 78 FR 54917, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: I Drug II II II II II II Cathinone (1235) .......................... Methcathinone (1237) .................. 4-Methyl-N-methylcathinone (1248). N-Ethylamphetamine (1475) ........ N,N-Dimethylamphetamine (1480) Fenethylline (1503) ....................... Aminorex (1585) ........................... 4-Methylaminorex (cis isomer) (1590). Gamma Hydroxybutyric Acid (2010). Methaqualone (2565) ................... XLR11 (7011) ............................... AKB48 (7048) ............................... 1-Pentyl-3-(1-naphthoyl)indole (7118). UR–144 (7144) ............................. 1-Butyl-3-(1-naphthoyl)indole (7173). The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers. With regards to amphetamine (1100), the company plans to procure the listed controlled substance in bulk from a domestic source in order to manufacture other controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the VerDate Mar<15>2010 Manufacturer of Controlled Substances; Notice of Registration; Cerilliant Corporation Jkt 232001 PO 00000 Frm 00104 Fmt 4703 Schedule Sfmt 4703 I I I I I I I I I I I I I I I Drug 1-[2-(4-Morpholinyl)ethyl]-3-(1naphthoyl) indole (7200). Alpha-ethyltryptamine (7249) ....... 5-(1,1-Dimethylheptyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol] (7297). 5-(1,1-Dimethyloctyl)-2-[(1R,3S)3hydroxycyclohexyl-phenol] (7298). Lysergic acid diethylamide (7315) 2,5-Dimethoxy-4-(n)propylthiophenethylamine (7348). Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Parahexyl (7374) .......................... Mescaline (7381) .......................... 3,4,5-Trimethoxyamphetamine (7390). 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 2,5-Dimethoxy-4ethylamphetamine (7399). 3,4-Methylenedioxyamphetamine (7400). 5-Methoxy-3,4methylenedioxyamphetamine (7401). N-Hydroxy-3,4methylendioxyamphetamine (7402). 3,4-Methylendioxy-Nethylamphetamine (7404). 3,4-Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) ... 5-Methoxy-N-Ndimethyltryptamine (7431). Alpha-methyltryptamine (7432) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 5-Methoxy-N,Ndiisopropyltryptamine (7439). N-Ethyl-1-phenylcyclohexylamine (7455). 1-(1-Phenylcyclohexyl)pyrrolidine (7458). 1-[1-(2Thienyl)cyclohexyl]piperidine (7470). N-Benzylpiperazine (7493) ........... Acetyldihydrocodeine (9051) ........ Benzylmorphine (9052) ................ Codeine-N-oxide (9053) ............... Codeine methylbromide (9070) .... Dihydromorphine (9145) ............... Heroin (9200) ............................... Hydromorphinol (9301) ................. Methyldesorphine (9302) .............. Methyldihydromorphine (9304) ..... Morphine methylbromide (9305) .. Morphine methylsulfonate (9306) Morphine-N-oxide (9307) ............. Normorphine (9313) ..................... E:\FR\FM\04FEN1.SGM 04FEN1 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 79, Number 23 (Tuesday, February 4, 2014)]
[Notices]
[Pages 6633-6634]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02207]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Cambridge Isotope Lab

    By Notice dated August 15, 2013, and published in the Federal 
Register on August 26, 2013, 78 FR 52802, Cambridge Isotope Lab, 50 
Frontage Road, Andover, Massachusetts 01810, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Morphine (9300), a basic class of controlled 
substance listed in schedule II.
    The company plans to utilize small quantities of the listed 
controlled substance in the preparation of analytical standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of

[[Page 6634]]

Cambridge Isotope Lab to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Cambridge Isotope Lab to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic class of controlled substance listed.

    Dated: January 15, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-02207 Filed 2-3-14; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.